查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945343

2026年全球免疫诊断市场报告

Immunodiagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，免疫诊断市场发展迅速，预计将从2025年的243.2亿美元成长到2026年的261.6亿美元，复合年增长率达7.5%。过去几年的成长可归因于感染疾病和慢性病的增加、临床实验室网路的扩张、对疾病早期检测需求的不断增长、基于抗体的诊断方法的广泛应用以及标准化免疫检测技术的普及。

预计未来几年免疫诊断市场将维持强劲成长，2030年市场规模将达到357.6亿美元，复合年增长率（CAGR）为8.1%。预测期内的成长要素包括：个人化诊断的日益普及、自动化检查室投资的增加、照护现场免疫诊断的扩展、人工智慧赋能的结果解读的日益整合，以及对预防性检测的日益重视。预测期内的主要趋势包括：自动化免疫检测设备的普及率不断提高、对高灵敏度诊断测试的需求不断增长、快速免疫诊断试剂盒的使用日益广泛、多重检测能力的提升以及实验室数据管理系统的日益整合。

预计未来几年，慢性病和感染疾病的增加将推动免疫诊断市场的成长。盛行率上升指的是患有长期或復发性疾病（例如癌症、自体免疫疾病、心血管疾病和慢性病毒感染疾病）的人数不断增加，这些疾病需要基于抗原-抗体反应进行重复诊断检测，以进行疾病检测和监测。人口老化和预期寿命延长导致多种合併症发病率上升，以及患有这些疾病的终生风险增加，进一步强化了这一趋势。免疫诊断市场在应对日益严重的疾病负担方面发挥关键作用，它能够早期识别疾病特异性生物标誌物，辅助治疗方法的选择，并在医院、诊断检查室和照护现场监测治疗效果。例如，根据总部位于瑞士的世界卫生组织（世卫组织）的数据，截至2025年6月，欧洲地区每年有180万人死于可预防的慢性非传染性疾病。

免疫诊断市场的主要企业正致力于开发创新解决方案，例如自动化化学冷光免疫检测（CLIA），以提高诊断准确性、缩短检测时间并提升检查室效率。同时，他们也在开发标靶检测方法，例如肺炎链球菌抗原免疫诊断检测，以辅助诊断肺炎球菌性肺炎。肺炎链球菌抗原免疫诊断检测旨在检测体液中的肺炎球菌抗原，从而实现肺炎链球菌感染的早期发现。自动化化学冷光免疫检测结合了发光化学和自动化技术，能够快速且准确地检测血液和其他检体中的特定蛋白质和抗体。例如，2025年9月，总部位于义大利的诊断公司DiaSorin SpA推出了用于评估自体免疫甲状腺疾病的LIAISON® TSH-R Ab检测。此检测方法采用双桥结构以提高抗体特异性，与现有的 LIAISON® 分析仪无缝整合以优化工作流程，并获得 CE 标誌认证，可在受监管的市场中使用。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球免疫诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 自动化免疫检测设备的应用日益普及
    • 对高灵敏度诊断测试的需求日益增长
    • 扩大快速免疫诊断试剂盒的使用范围
    • 扩展的多重测试能力
    • 加强检查室数据管理系统的集成

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 诊断检查室
  • 学术研究机构
  • CRO（受託研究机构）

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球免疫诊断市场：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 全球免疫诊断市场规模、对比及成长率分析
  • 全球免疫诊断市场表现：规模与成长，2020-2025年
  • 全球免疫诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 试剂、耗材和设备
  • 透过技术
  • 酵素免疫分析法、化学冷光免疫检测、萤光免疫分析、快速检测及其他技术
  • 透过使用
  • 感染疾病、肿瘤学和内分泌学、骨骼和矿物质疾病、自体免疫疾病、心臟生物标记、药物监测及其他应用
  • 最终用户
  • 医院、诊所和诊断检查室
  • 按类型细分：试剂和耗材
  • 抗体、检测试剂盒、缓衝液和基材
  • 按类型细分：设备
  • 免疫检测分析仪，ELISA 阅读器

第十章 区域与国家分析

  • 全球免疫诊断市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球免疫诊断市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 免疫诊断市场：竞争格局及市场占有率（2024年）
  • 免疫诊断市场：公司估值矩阵
  • 免疫诊断市场：公司概况
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.

第37章：其他领先和创新企业

  • Bio-Rad Laboratories Inc., DiaSorin SpA, bioMerieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols SA, Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年免疫诊断市场：提供新机会的国家
  • 2030年免疫诊断市场：充满新机会的细分市场
  • 2030年免疫诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MIMMU03_G26Q1

Immunodiagnostics is a diagnostic approach that relies primarily on the antigen-antibody response for detecting serum insulin. These tests are employed to identify antibodies and parasite antigens.

The principal products in the field of immunodiagnostics include reagents and consumables, instruments and software, and services. Reagents are substances used to initiate chemical reactions with other substances to detect the presence of specific substances, while consumables refer to traceable items utilized in the execution of analysis techniques. The technologies involved encompass enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, rapid tests, and others. These technologies find applications in various medical fields such as infectious diseases, oncology, endocrinology, bone and mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and more. The end-users of immunodiagnostics include hospitals, clinics, diagnostic laboratories, academic and research institutes, among others.

Tariffs are influencing the immunodiagnostics market by increasing costs of imported reagents, antibodies, assay kits, diagnostic instruments, and electronic components used in immunoassay analyzers. Diagnostic laboratories and hospitals in North America and Europe are most affected due to dependence on imported consumables and instruments, while Asia-Pacific faces pricing pressure on manufacturing and exports. These tariffs are raising test costs and impacting procurement budgets. However, they are also driving localization of reagent production, regional manufacturing of diagnostic instruments, and innovation in cost-efficient immunodiagnostic solutions.

The immunodiagnostics market research report is one of a series of new reports from The Business Research Company that provides immunodiagnostics market statistics, including immunodiagnostics industry global market size, regional shares, competitors with a immunodiagnostics market share, detailed immunodiagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the immunodiagnostics industry. This immunodiagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunodiagnostics market size has grown strongly in recent years. It will grow from $24.32 billion in 2025 to $26.16 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing prevalence of infectious and chronic diseases, expansion of clinical laboratory networks, growing demand for early disease detection, rising use of antibody-based diagnostics, availability of standardized immunoassay technologies.

The immunodiagnostics market size is expected to see strong growth in the next few years. It will grow to $35.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing adoption of personalized diagnostics, rising investments in automated laboratories, expansion of point-of-care immunodiagnostics, growing integration of AI-based result interpretation, increasing focus on preventive healthcare testing. Major trends in the forecast period include increasing adoption of automated immunoassay analyzers, rising demand for high-sensitivity diagnostic tests, growing use of rapid immunodiagnostic kits, expansion of multiplex testing capabilities, enhanced integration of laboratory data management systems.

The increasing prevalence of chronic and infectious diseases is expected to drive the growth of the immunodiagnostics market in the coming years. Rising prevalence refers to the growing number of individuals living with long-term or recurring conditions such as cancer, autoimmune disorders, cardiovascular diseases, and chronic viral infections that require repeated diagnostic testing based on antigen-antibody interactions for disease detection and monitoring. This trend continues to intensify as populations age and life expectancy increases, leading to a higher incidence of multiple comorbidities and a greater lifetime risk of developing such conditions. The immunodiagnostics market plays a critical role in addressing this expanding disease burden by enabling early identification of disease-specific biomarkers, supporting treatment selection, and monitoring therapeutic response across hospitals, diagnostic laboratories, and point-of-care settings. For instance, in June 2025, according to the World Health Organization (WHO), a Switzerland-based organization, 1.8 million avoidable deaths occur each year in the European region due to chronic noncommunicable diseases.

Major companies operating in the immunodiagnostics market are increasingly emphasizing the development of innovative solutions such as automated chemiluminescence immunoassays (CLIAs) to improve diagnostic accuracy, shorten testing time, and enhance laboratory efficiency. In parallel, companies are also advancing targeted assays such as the S. pneumoniae antigen immunodiagnostic assay to support the diagnosis of pneumococcal pneumonia. The S. pneumoniae antigen immunodiagnostic assay is designed to detect Streptococcus pneumoniae antigens in bodily fluids, enabling timely identification of pneumococcal infections. Automated chemiluminescence immunoassays use light-emitting chemical reactions combined with automation to rapidly and precisely detect specific proteins or antibodies in blood or other samples. For instance, in September 2025, DiaSorin S.p.A., an Italy-based diagnostics company, launched the LIAISON(R) TSH-R Ab assay for the assessment of autoimmune thyroid disorders. The assay offers improved antibody specificity through a double-bridge architecture, integrates seamlessly with existing LIAISON(R) analyzers to optimize workflows, and features CE-marked compatibility for use across regulated markets.

In May 2023, Freenome, a biotechnology company based in the U.S., acquired Oncimmune for an undisclosed amount. This acquisition is intended to enhance Freenome's capabilities in early cancer detection by incorporating Oncimmune's innovative technology and expertise in immune profiling. The move aims to strengthen Freenome's position in the oncology diagnostics market and expand its portfolio of liquid biopsy solutions. Oncimmune, located in the UK, specializes in developing technologies for immune profiling and biomarker discovery to aid in cancer diagnosis and monitoring.

Major companies operating in the immunodiagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMerieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp., OraSure Technologies Inc., Immunodiagnostic Systems Holdings Plc (IDS)

North America was the largest region in the immunodiagnostics market in 2025. The regions covered in the immunodiagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunodiagnostics market consists of revenues earned by entities by providing agglutination, nephelometry, immunoprecipitation, and radial immunodiffusion test services. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunodiagnostics market also includes sales of anti-streptolysin-O latex, infectious mononucleosis slide, rheumatoid factor, and syphilis serology reagent. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunodiagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunodiagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunodiagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Reagents And Consumables; Instruments
  • 2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Rapid Test; Other Technologies
  • 3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Drug Monitoring; Other Applications
  • 4) By End User: Hospitals; Clinics; Diagnostic Laboratories
  • Subsegments:
  • 1) By Reagents And Consumables: Antibodies; Assay Kits; Buffers And Substrates
  • 2) By Instruments: Immunoassay Analyzers; ELISA Readers
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; Danaher Corporation; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; bioMerieux SA; Sysmex Corporation; Becton Dickinson and Company; Grifols S.A.; Ortho Clinical Diagnostics; Beckman Coulter Inc.; Fujirebio Holdings Inc.; Quidel Corporation; Luminex Corporation; Bio-Techne Corporation; PerkinElmer Inc.; Merck KGaA; Gold Standard Diagnostics Corp.; OraSure Technologies Inc.; Immunodiagnostic Systems Holdings Plc (IDS)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Immunodiagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Immunodiagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Immunodiagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Immunodiagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Automated Immunoassay Analyzers
    • 4.2.2 Rising Demand For High-Sensitivity Diagnostic Tests
    • 4.2.3 Growing Use Of Rapid Immunodiagnostic Kits
    • 4.2.4 Expansion Of Multiplex Testing Capabilities
    • 4.2.5 Enhanced Integration Of Laboratory Data Management Systems

5. Immunodiagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Diagnostic Laboratories
  • 5.4 Academic Research Institutes
  • 5.5 Contract Research Organizations

6. Immunodiagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunodiagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Immunodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Immunodiagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Immunodiagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Immunodiagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunodiagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunodiagnostics Market Segmentation

  • 9.1. Global Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Consumables, Instruments
  • 9.2. Global Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, Other Technologies
  • 9.3. Global Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
  • 9.4. Global Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Diagnostic Laboratories
  • 9.5. Global Immunodiagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibodies, Assay Kits, Buffers And Substrates
  • 9.6. Global Immunodiagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunoassay Analyzers, ELISA Readers

10. Immunodiagnostics Market Regional And Country Analysis

  • 10.1. Global Immunodiagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Immunodiagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunodiagnostics Market

  • 11.1. Asia-Pacific Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunodiagnostics Market

  • 12.1. China Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunodiagnostics Market

  • 13.1. India Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunodiagnostics Market

  • 14.1. Japan Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunodiagnostics Market

  • 15.1. Australia Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunodiagnostics Market

  • 16.1. Indonesia Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunodiagnostics Market

  • 17.1. South Korea Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunodiagnostics Market

  • 18.1. Taiwan Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunodiagnostics Market

  • 19.1. South East Asia Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunodiagnostics Market

  • 20.1. Western Europe Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunodiagnostics Market

  • 21.1. UK Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunodiagnostics Market

  • 22.1. Germany Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunodiagnostics Market

  • 23.1. France Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunodiagnostics Market

  • 24.1. Italy Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunodiagnostics Market

  • 25.1. Spain Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunodiagnostics Market

  • 26.1. Eastern Europe Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunodiagnostics Market

  • 27.1. Russia Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunodiagnostics Market

  • 28.1. North America Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunodiagnostics Market

  • 29.1. USA Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunodiagnostics Market

  • 30.1. Canada Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunodiagnostics Market

  • 31.1. South America Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunodiagnostics Market

  • 32.1. Brazil Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunodiagnostics Market

  • 33.1. Middle East Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunodiagnostics Market

  • 34.1. Africa Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunodiagnostics Market Regulatory and Investment Landscape

36. Immunodiagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Immunodiagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Immunodiagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Immunodiagnostics Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Immunodiagnostics Market Other Major And Innovative Companies

  • Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMerieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp.

38. Global Immunodiagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunodiagnostics Market

40. Immunodiagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Immunodiagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Immunodiagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Immunodiagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer